http://www.xconomy.com/boston/2013/04/1 ... dsourcing/
This concept gives new hope to the thought that therapies that cannot be patented could still gain the statistically significant status needed to be accepted by the medical community.
There is a wealth of anecdotal data supporting things like:
Wheldon Protocol (ABX antibiotic regimens)
Procarin / histamine (Prokarin)
Low Dose Naltrexone (LDN)
Swank diet & supplement regimen
But these potentially life-altering therapies aren't even ...